CAS: 1246819-50-0
Febuxostat D9
CAS:1246819-50-0
Febuxostat D9 is deuterium labeled Febuxostat, which is a selective xanthine oxidase inhibitor with Ki …
Formula:
C16H16N2O3S
Molecular weight:
325.43
Ref: TM-T11270
| 1mg | 249.00 € |
Estimated delivery in United States, on Tuesday 30 Apr 2024
Febuxostat-d9
CAS:1246819-50-0
Formula:
C16H7D9N2O3S
Color and Shape:
White To Off-White Solid
Molecular weight:
325.43
Ref: 4Z-F-393
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 3 May 2024
Ref: 3U-D8109
| 5mg | 815.00 € | |
| 10mg | 1,361.00 € |
Estimated delivery in United States, on Monday 6 May 2024
Febuxostat-d9
Controlled ProductCAS:1246819-50-0
Applications Labelled Febuxostat (F229000). Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic …
Formula:
C16H7D9N2O3S
Color and Shape:
White to Off-White Solid
Molecular weight:
325.43
Ref: TR-F229002
| 1mg | 277.00 € | |
| 10mg | 1,857.00 € |
Estimated delivery in United States, on Wednesday 12 Jun 2024
Febuxostat-D9
CAS:1246819-50-0
Febuxostat-D9 is a drug that inhibits the production of uric acid. It is used to …
Formula:
C16H7D9N2O3S
Purity:
Min. 95%
Molecular weight:
325.43 g/mol
Ref: 3D-WZB81950
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024
